SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)

Active, not recruitingOBSERVATIONAL
Enrollment

17,602

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

September 5, 2025

Study Completion Date

December 31, 2025

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

HPV testing

Interviews will be conducted among women from the general population and HIV+ women after screening for HPV. A small subset of participants will be interviewed after receiving treatment for precancer. HPV test results and outcome of the precancer treatment if indicated will be documented.

Trial Locations (4)

1103

Metro-Manila, Quezon City

Unknown

CMA de Do, Ouagadougou

FSU Koko, Bouaké

Quetzaltenango, Quetzaltenango

All Listed Sponsors
collaborator

UNITAID

OTHER

collaborator

Expertise France

OTHER

collaborator

World Health Organization

OTHER

lead

Jhpiego

OTHER